Cue Health
Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.
Also: Elligo Health Research brings in $135 million, and digital dental care startup Membersy raises $66 million.
The company currently has more than $664 million in funding.
Also, British medtech company Smith+Nephew launches its robotics platform in India.
The new capital will be used to accelerate Cue’s growth.
The system delivers its results to a companion app in about 20 minutes, according to the agency.
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
The San Diego startup will deliver six million rapid molecular test kits to the government by March 2021.
The Cue Health Monitoring System can deliver its results through a smartphone dashboard, and is intended for use by health professionals and consumers alike.